Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:08 pm Sale | 2024-12-31 | 13G | NLS Pharmaceutics AG NLSP | Lind Global Fund II LP | 59,780 4.900% | -43,750 (-42.26%) | Filing History |
| 2024-11-21 4:01 pm Purchase | 2024-09-30 | 13G | NLS Pharmaceutics AG NLSP | Hafner Ronald | 310,958 8.100% | 310,958 (New Position) | Filing History |
| 2024-11-14 7:27 pm Purchase | 2024-09-30 | 13G | NLS Pharmaceutics AG NLSP | Lind Global Fund II LP | 103,530 8.100% | 103,530 (New Position) | Filing History |
| 2024-11-14 3:33 pm Purchase | 2024-09-30 | 13G | NLS Pharmaceutics AG NLSP | ARMISTICE CAPITAL LLC | 129,475 9.990% | 129,475 (New Position) | Filing History |
| 2024-11-04 7:39 pm Sale | 2024-09-30 | 13G | NLS Pharmaceutics AG NLSP | YA II PN Ltd. | 0 0.000% | -98,978 (Position Closed) | Filing History |
| 2024-11-04 6:20 pm Purchase | 2024-09-30 | 13G | NLS Pharmaceutics AG NLSP | Grisard Felix | 107,366 2.800% | 26,294 (+32.43%) | Filing History |
| 2024-10-15 1:24 pm Purchase | 2024-10-10 | 13G | NLS Pharmaceutics AG NLSP | ALPHA CAPITAL ANSTALT | 246,996 9.990% | 246,996 (New Position) | Filing History |
| 2024-03-27 7:37 pm Purchase | 2024-03-22 | 13G | NLS Pharmaceutics AG NLSP | Lind Global Fund II LP | 107,500 9.900% | 107,500 (New Position) | Filing History |
| 2024-02-12 4:37 pm Purchase | 2023-12-31 | 13G | NLS Pharmaceutics AG NLSP | YA II PN Ltd. | 98,978 9.990% | 22,803 (+29.93%) | Filing History |
| 2023-02-24 07:55 am Purchase | 2022-10-02 | 13G | NLS Pharmaceutics AG NLSP | Grisard Felix | 81,072 9.990% | 81,072 (New Position) | Filing History |
| 2023-02-14 4:32 pm Sale | 2022-12-31 | 13G | NLS Pharmaceutics AG NLSP | Magnetic Rock Investment AG | 71,125 8.770% | -10,250 (-12.60%) | Filing History |
| 2023-02-13 7:32 pm Purchase | 2022-12-31 | 13G | NLS Pharmaceutics AG NLSP | Konofal Eric | 25,625 3.200% | 125 (+0.49%) | Filing History |
| 2023-02-13 4:02 pm Purchase | 2022-12-31 | 13G | NLS Pharmaceutics AG NLSP | Zwyer Alexander | 31,350 3.900% | 1,350 (+4.50%) | Filing History |
| 2023-01-03 3:58 pm Purchase | 2022-12-31 | 13G | NLS Pharmaceutics AG NLSP | YA II PN Ltd. | 76,175 9.990% | 36,030 (+89.75%) | Filing History |
| 2022-12-16 4:45 pm Purchase | 2022-12-06 | 13G | NLS Pharmaceutics AG NLSP | BIOTECHNOLOGY VALUE FUND L P | 171,479 19.990% | 171,479 (New Position) | Filing History |
| 2022-02-24 06:06 am Purchase | 2021-12-31 | 13G | NLS Pharmaceutics AG NLSP | Konofal Eric | 25,500 6.300% | 25,500 (New Position) | Filing History |
| 2022-02-18 5:30 pm Purchase | 2021-12-31 | 13G | NLS Pharmaceutics AG NLSP | Magnetic Rock Investment AG | 81,375 20.000% | 81,375 (New Position) | Filing History |
| 2022-02-14 08:03 am Purchase | 2021-12-31 | 13G | NLS Pharmaceutics AG NLSP | Zwyer Alexander | 30,000 7.400% | 30,000 (New Position) | Filing History |
| 2022-01-11 4:52 pm Purchase | 2021-12-31 | 13G | NLS Pharmaceutics AG NLSP | YA II PN Ltd. | 40,146 9.990% | 6,660 (+19.89%) | Filing History |
| 2021-10-07 6:24 pm Purchase | 2021-10-07 | 13G | NLS Pharmaceutics AG NLSP | YA II PN Ltd. | 33,486 9.990% | 33,486 (New Position) | Filing History |